Article Text
DTB select
Spironolactone for acne in women
Abstract
Overview of: Santer M, Lawrence M, Renz S, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023;381:e074349.
- Health Care Quality, Access, and Evaluation
- Drug-Related Side Effects and Adverse Reactions